
ESMO 2022 Conference Coverage
Lecture Summary - ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma
By
ESMO 2022 Conference Coverage
FEATURING
Han Chong Toh
By
ESMO 2022 Conference Coverage
FEATURING
Han Chong Toh
15 views
September 22, 2022
Comments 0
Login to view comments.
Click here to Login
Head and Neck